The European Medicines Agency (EMA) and the European Centre for Disease Prevention and Control (ECDC) convened on 6 and 7 December in Amsterdam the first meeting of the Immunisation and Vaccine Monitoring Advisory Board (IVMAB) of the Vaccine Monitoring Platform (VMP).
The VMP is a joint initiative of the two Agencies for strengthening the continuous monitoring of the safety and effectiveness of vaccines in the European Union (EU).
Through the VMP, EMA and ECDC will coordinate and oversee EU-funded, independent post-authorisation studies on vaccines use, safety and effectiveness conducted in EU countries.
“With the new vaccines monitoring platform we have an instrument in place through which we will prioritise research, fund independent studies and complement our knowledge of how vaccines work in real life”, said Emer Cooke, EMA’s Executive Director, in her opening remarks…
